Exchange: NASDAQ·Updated 06:01 AM EDT
RARE logo

RARE Ultragenyx Pharmaceutical Inc

$14.71
$11.82
(44.55%)
Pre-Market
Prev Close $26.53
Reported EarningsAug 4
Mkt Cap$2.54B
Vol212,972.00

About RARE

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.
93

Extremely Bullish Sentiment

How do you feel about RARE?

Advertisement|Remove ads.